Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-09-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1996 |